Stockscreener 앱 받기
4.01
2.67%
-0.11
시간 외 거래:
4.10
0.09
+2.24%
전일 마감가:
$4.12
열려 있는:
$4.08
하루 거래량:
849.38K
Relative Volume:
1.19
시가총액:
$260.14M
수익:
$207.32M
순이익/손실:
$-61.04M
주가수익비율:
-4.1871
EPS:
-0.9577
순현금흐름:
$-25.97M
1주 성능:
-5.20%
1개월 성능:
+50.75%
6개월 성능:
+55.43%
1년 성능:
-26.29%
1일 변동 폭
$3.91
$4.255
1주일 범위
$3.755
$4.469
52주 변동 폭
$1.17
$7.78
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.01 | 254.30M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Treace Medical Concepts Balances Growth With Earnings Strain - TipRanks
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock - Investing.com UK
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock By Investing.com - Investing.com South Africa
Treace Medical (TMCI) CEO boosts direct stake with June share buys - Stock Titan
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock - Investing.com
Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases - Stock Titan
Treace to Present at the Sidoti Small Cap Conference - The Manila Times
TMCI Q1 2026 Earnings: Narrowed Loss Beats Expectations Amidst Operational FocusEarnings Call Transcript - newsline.com
Treace Medical CEO John Treace buys $177,915 in company stock By Investing.com - Investing.com Nigeria
Treace Medical CEO John Treace buys $177,915 in company stock - Investing.com
Treace Medical (TMCI) CEO buys 50,000 shares in open-market trade - Stock Titan
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com Australia
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
William Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (TMCI) Declines 2.11% as Stock Nears Key Support at $2.64Covered Call ETF - The Legal Advocate
Treace Medical Concepts, Inc. 8-K SEC Filing Details and Company Information (May 19, 2026) - Minichart
Treace Medical Shareholders Back Directors, Pay and Auditor - TipRanks
Treace Medical Concepts shareholders elect directors and approve key proposals - Investing.com Australia
Treace Medical Concepts shareholders elect directors and approve key proposals By Investing.com - Investing.com South Africa
Treace Medical (TMCI) shareholders elect directors and ratify auditor at 2026 meeting - Stock Titan
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Treace Medical (TMCI) receives 30,000 restricted stock units - Stock Titan
Treace Medical (NASDAQ: TMCI) director gets 30,000 RSUs, holds 75,243 - Stock Titan
Armistice Capital (TMCI) discloses 6.36M shares, 9.85% stake - Stock Titan
Treace Medical Concepts Q1 earnings call highlights - MSN
Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing - Moomoo
Treace Medical Concepts CEO John Treace buys $375,505 in shares By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John Treace buys $375,505 in shares - Investing.com
TMCI (TMCI) CEO John Treace purchases over 150,000 company shares in open market - Stock Titan
Bank of America (TMCI) reports 3.53M shares, 5.5% ownership - Stock Titan
Treace Medical Concepts, Inc. Shareholders Are Encouraged - GlobeNewswire
Treace Medical Concepts (TMCI) Price Target Decreased by 35.65% to 5.58 - MSN
Treace Medical Concepts Q1 Earnings Call Highlights - MarketBeat
Treace Medical Concepts: Q1 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Hikes on Q1 Numbers - Baystreet.ca
Treace Medical Concepts, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts By Investing.com - Investing.com Australia
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트리스 메디컬 컨셉트 주식 (TMCI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Treace John T. | Chief Executive Officer |
Jun 11 '26 |
Buy |
4.04 |
22,887 |
92,541 |
7,376,150 |
| Treace John T. | Chief Executive Officer |
Jun 01 '26 |
Buy |
3.56 |
50,000 |
177,915 |
7,323,833 |
| Treace John T. | Chief Executive Officer |
May 28 '26 |
Buy |
3.02 |
61,202 |
184,824 |
7,273,833 |
| Treace John T. | Chief Executive Officer |
May 27 '26 |
Buy |
2.87 |
49,810 |
143,189 |
7,212,631 |
| Treace John T. | Chief Executive Officer |
May 26 '26 |
Buy |
2.79 |
4,508 |
12,576 |
7,162,821 |
| Treace John T. | Chief Executive Officer |
May 14 '26 |
Buy |
2.62 |
61,750 |
161,495 |
7,158,313 |
| Treace John T. | Chief Executive Officer |
May 13 '26 |
Buy |
2.46 |
49,013 |
120,533 |
7,096,563 |
| Treace John T. | Chief Executive Officer |
May 12 '26 |
Buy |
2.17 |
43,000 |
93,478 |
7,047,550 |
| Scanlan Sean F. | Chief Innovation Officer |
Feb 10 '26 |
Option Exercise |
1.05 |
16,875 |
17,719 |
706,474 |
| Scanlan Sean F. | Chief Innovation Officer |
Jan 21 '26 |
Option Exercise |
0.72 |
53,500 |
38,520 |
427,099 |
2.43%
자본화:
|
볼륨(24시간):